Our results revealed a unique interplay between liprin-α1 and CD82 transmembrane protein in the invasion of HNSCC and breast cancer cells, thus providing mechanistic details of liprin-α1 function in cancer cell progression. This evidence concerns the gene CD82 and cancer.